Revenue performance: QQ1 2025 revenue of $2,142,784,000, down 14.31% YoY and down 15.44% QoQ.
Gross profit: $281,442,000 with a gross margin of 13.13%; YoY gross profit decline of 21.37% and QoQ decline of 29.87%.
Profitability: EBITDA $81,733,000 with EBITDAR ~3.81% of revenue; Operating income $41,245,000 and operating margin ~1.92%. Net income after tax was negative $1,832,000; net margin approximately -0.08%. EPS diluted: -0.0346; YoY and QoQ EPS declines around 103.5%.
Cash flow and liquidity: Net cash provided by operating activities $30,740,000; free cash flow $5,467,000. Capital expenditures were $25,273,000, yielding a modest free cash flow position despite the net loss. Cash and cash equivalents at period end: $445,222,000; total debt approximately $32,206,000; net debt negative by about $413,016,000 due to sizable cash.
Balance sheet health: Total assets $6.873 billion; total liabilities $2.811 billion; total stockholdersโ equity $4.054 billion. Current ratio 1.71; quick ratio 0.784; cash ratio 0.301. Inventory $1.372 billion; accounts receivable $638.4 million; days sales outstanding ~26.8 days; inventory days ~67.5 days; receivables turnover 3.36, inventory turnover 1.334.
Valuation context: Price to sales ~2.60; price to book ~1.37; price to earnings negative due to the quarterly loss; enterprise value multiple ~77.26. The data suggests a high multiple in the current cyclically challenged environment, underscoring the need for a durable recovery in volume or margin to justify valuation levels.